Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020
Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
The non-tuberculous pulmonary disease experience in a general respiratory clinic in the UK Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 Year: 2021
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017
Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017 Year: 2018
Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
How the tuberculosis infected immigrants in Greece react after the diagnosis of their disease by the primary health care system? Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010
Studying lung inflammatory biomarkers using non-invasive methods in patients with community acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002
Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1901300; 10.1183/13993003.01300-2019 Year: 2020